Trend of anti-tuberculosis drug resistance in Korea, 1994-2004

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 5, 2007, Pages 571-576

  Bai, Gill Han ^a,e   Park, Y K ^a   Choi, Y W ^a   Bai, J I ^a   Kim, H J ^a   Chang, C L ^a,b   Lee, J K ^c   Kim, S J ^d  

^a Korean Institute of Tuberculosis   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Ministry of Health and Welfare   (South Korea)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e 1012 Jookjeon Xi Apartment ^*  (South Korea)

Author keywords

Drug resistance; Prevalence; Tuberculosis

Indexed keywords

CAPREOMYCIN; KANAMYCIN; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; CONFIDENCE INTERVAL; DRUG RESISTANCE; HEALTH CENTER; HUMAN; KOREA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SMEAR; STATISTICAL ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; ETHAMBUTOL; HUMANS; ISONIAZID; KOREA; MIDDLE AGED; PREVALENCE; PYRAZINAMIDE; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 34248324824     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/CDC/TB/2003.320. Geneva, Switzerland: WHO, 2003.
2. Kim S J. Current problems of drug resistant tuberculosis and its control. Kekkaku 2002; 77: 735-740.
3. Kim S J, Hong Y P. Drug resistance of Mycobacterium tuberculosis in Korea. Tubercle Lung Dis 1992; 73: 219-224.
4. Kim S J, Bai G H, Hong Y P. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997; 1: 302-308.
5. Wane L G. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974; 109: 147-151.
6. Bai G H, Kim S J. Study on the pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Tuberc Respir Dis 1983; 30: 103-112. [Korean]
7. Lwanga S K, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva, Switzerland: World Health Organization, 1991.
8. Fleiss J L. Statistical methods for rates and proportions. New York, NY, USA: John Wiley, 1982: pp 173-175.
9. Hong Y P, Kim S J, Lew W J, Lee S H, Lee E K. Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994. Int J Tuberc Lung Dis 1998; 2: 365-371.
10. Jin B W, Jang D J. An analysis of tuberculosis patient management in private sector. Tuberc Respir Dis 1990; 37: 399-406. [Korean]
11. Hong Y P, Kim S J, Lee E G, Lew W J, Bai J Y. Treatment of bacillary pulmonary tuberculosis at the chest clinics in the private sector in Korea, 1993. Int J Tuberc Lung Dis 1999; 3: 695-702.
12. Korea Center for Disease Control and Prevention, Korean Institute of Tuberculosis: Annual report on notified tuberculosis patients in Korea (Based on Korean Tuberculosis Surveillance System). Seoul, Republic of Korea: KIT, 2006.
13. Hong Y P, Kim S J, Lew W J, Lee E K, Han Y C. The seventh nationwide tuberculosis prevalence surveys in Korea, 1995. Int J Tuberc Lung Dis 1998; 2: 27-36.
14. World Health Organization, TB Strategy and Operations, Stop TB Department. Involving private practitioners in tuberculosis control: issues, interventions, and emerging policy framework. WHO/CDS/TB/2001.285. Geneva, Switzerland: WHO, 2001.
15. Ministry of Health and Welfare, Korea. The guidelines of the national TB control programme. Seoul, Korea: Ministry of Health and Welfare, 1991.
16. Wright A, Bai G, Barrera L, et al. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR 2006; 55: 301-305.